Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex
- PMID: 8265587
- PMCID: PMC48021
- DOI: 10.1073/pnas.90.24.11548
Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex
Abstract
Receptor-mediated endocytosis is an effective method for gene delivery into target cells. We have previously shown that DNA molecules complexed with asialoglycoprotein can be efficiently endocytosed by primary hepatocytes and the internalized DNA can be released from endosomes by the use of a replication-defective adenovirus. Because the DNA and virus enter target cells independently, activity enhancement requires high concentrations of adenoviral particles. In this study, adenoviral particles were chemically conjugated to poly(L-lysine) and bound ionically to DNA molecules. Quantitative delivery to primary hepatocytes was achieved with significantly reduced viral titer when the asialoorosomucoid-poly(L-lysine) conjugate was included in the complex. The conjugated adenovirus was used to deliver a DNA vector containing canine factor IX to mouse hepatocytes, resulting in the expression of significant concentrations of canine factor IX in the culture medium. The results suggest that receptor-mediated endocytosis coupled with an efficient endosomal lysis vector should permit the application of targeted and efficient gene delivery into the liver for gene therapy of hepatic deficiencies.
Similar articles
-
Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes.Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2122-6. doi: 10.1073/pnas.90.6.2122. Proc Natl Acad Sci U S A. 1993. PMID: 8384712 Free PMC article.
-
Biochemical and functional analysis of an adenovirus-based ligand complex for gene transfer.Biochem J. 1994 Apr 1;299 ( Pt 1)(Pt 1):49-58. doi: 10.1042/bj2990049. Biochem J. 1994. PMID: 8166659 Free PMC article.
-
Efficient transfection of primary cells in a canine hemophilia B model using adenovirus-polylysine-DNA complexes.Hum Gene Ther. 1994 Mar;5(3):313-22. doi: 10.1089/hum.1994.5.3-313. Hum Gene Ther. 1994. PMID: 8018746
-
Delivery systems for gene therapy.Biotherapy. 1991;3(1):87-95. doi: 10.1007/BF02175102. Biotherapy. 1991. PMID: 2009217 Review.
-
Delivery of DNA into mammalian cells by receptor-mediated endocytosis and gene therapy.Mol Biotechnol. 1995 Jun;3(3):237-48. doi: 10.1007/BF02789334. Mol Biotechnol. 1995. PMID: 7552693 Review.
Cited by
-
Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene delivery.Int J Nanomedicine. 2006;1(4):507-22. doi: 10.2147/nano.2006.1.4.507. Int J Nanomedicine. 2006. PMID: 17369870 Free PMC article.
-
Administration route-dependent induction of antitumor immunity by interferon-alpha gene transfer.Cancer Sci. 2010 Jul;101(7):1686-94. doi: 10.1111/j.1349-7006.2010.01578.x. Epub 2010 Mar 25. Cancer Sci. 2010. PMID: 20487262 Free PMC article.
-
Prolonged activation of the mitogen-activated protein kinase pathway promotes DNA synthesis in primary hepatocytes from p21Cip-1/WAF1-null mice, but not in hepatocytes from p16INK4a-null mice.Biochem J. 1998 Dec 15;336 ( Pt 3)(Pt 3):551-60. doi: 10.1042/bj3360551. Biochem J. 1998. PMID: 9841865 Free PMC article.
-
Pharmaceutical approach to somatic gene therapy.Pharm Res. 1996 Nov;13(11):1595-614. doi: 10.1023/a:1016420102549. Pharm Res. 1996. PMID: 8956323 Review.
-
The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic.Biochem J. 1998 Mar 15;330 ( Pt 3)(Pt 3):1451-60. doi: 10.1042/bj3301451. Biochem J. 1998. PMID: 9494119 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical